For more than 20 years, NIAID has funded the Sexual Awareness for Everyone (SAFE) study at The University of Texas Health Science Center, San Antonio to reduce risky behaviors that often lead to STDs.
Volunteer for NIAID-funded clinical studies related to sexually transmitted diseases on ClinicalTrials.gov.
Join us! Volunteer today for HIV research studies.
Sexually transmitted diseases (STDs) are an important global health priority because of their devastating impact on women and infants and their inter-relationships with HIV/AIDS. STDs and HIV are linked by biological interactions and because both infections occur in the same populations. Infection with certain STDs can increase the risk of getting and transmitting HIV as well as alter the way the disease progresses. In addition, STDs can cause long-term health problems, particularly in women and infants. Some of the health complications that arise from STDs include pelvic inflammatory disease, infertility, tubal or ectopic pregnancy, cervical cancer, and perinatal or congenital infections in infants born to infected mothers.
NIAID supports research for more effective prevention and treatment approaches to control STDs. This includes:
In addition to its key research areas, NIAID addresses emerging issues related to STDs. For example, antimicrobial (drug) resistance has impeded the treatment of several STDs, most notably gonorrhea. NIAID supports research to better understand the mechanisms of resistance and discover alternate treatments.
Bulletin: Genital Herpes Vaccine Moderately Protective against One of Two Herpes Viruses—Jan. 5, 2012
Q & A: The Herpevac Trial for Women—Jan. 5, 2012
Media Availability: Scientists Find Method to Probe Genes of the Most Common Bacterial STI—April 11, 2011
Statement: Study Finds Genital Herpes Vaccine Ineffective in Women—Sept. 30, 2010
News from NIAID-Supported Institutions
Last Updated March 05, 2012
Last Reviewed April 11, 2011